Opioids are our most effective tool for treating pain, but what if there were a better way to stop pain without relying on addictive substances? To develop a non-addictive painkiller, scientists have been searching for proteins that appear on pain neurons but not in the reward pathway, and this has been no small task.
Vapogenix, a Houston pain medicine startup that’s developing a localized analgesic that penetrates the skin quickly, just raised a tidy sum – $2.1 million, according to a regulatory filing. The company won’t say which small molecule drug it’s working with, but that it’s a reformulated a non-narcotic pain drug that’s typically used as an inhalant […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.